We are a drug discovery and development company focused on the CNS area. We have a robust IP portfolio comprising composition of matter patents and a platform technology patent (sublicensed to Cerca Insights to provide screening services). We have identified 6 biological active leads through this platform technology and are currrently in the preclinical stage.